The Company capitalizes its purchases of saleable inventory of VASCEPA from suppliers that have been qualified by regulatory authorities. Inventories as of September 30, 2022 and December 31, 2021 consist of the following:


In thousands	September 30, 2022		December 31, 2021
Raw materials	$	128,921	$	107,695
Work in process		59,017		41,965
Finished goods (1)		227,632		206,270
Total inventory	$	415,570	$	355,930

(1) - During the nine months ended September 30, 2022 approximately $9.6 million of inventory was expensed through Cost of goods sold related to unsellable inventory not related to product dating.

As of September 30, 2022 and December 31, 2021, the Company had $188.0 million and $121.3 million of Long-term inventory, respectively, as consumption is expected beyond the Company's operating cycle.